Summary
Guardant Health, Inc. (GH) announced its financial results for the fiscal quarter ended June 30, 2021, via a press release filed on August 5, 2021. While the 8-K filing itself does not contain the detailed financial figures, it directs investors to an accompanying press release (Exhibit 99.1) for this information. Investors should refer to this press release for a comprehensive understanding of the company's performance during the second quarter of 2021, including revenue, profitability, and any forward-looking guidance provided by management.
Key Highlights
- 1Guardant Health reported its Q2 2021 financial results on August 5, 2021.
- 2The full details of the financial results are available in a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3Investors need to consult the press release for specific financial metrics such as revenue, net income/loss, and earnings per share.
- 4The filing incorporates the press release by reference, making its content an integral part of the disclosure.
- 5The information furnished is not considered 'filed' for Section 18 of the Exchange Act, meaning it does not carry the same legal implications as a formally filed document under that section.
Frequently Asked Questions
The specific financial results for the quarter ended June 30, 2021, are detailed in the press release furnished as Exhibit 99.1 to the Form 8-K filing dated August 5, 2021. Investors should review this press release for detailed financial performance.
When information is furnished and not 'filed' under Section 18 of the Securities Exchange Act of 1934, it means the company is providing the information but is not subject to the same level of liability for its accuracy and completeness as if it were formally filed. However, it is still considered important disclosure for investors.
This 8-K filing primarily serves to announce the results of operations and financial condition for the past quarter by referencing the press release. Any forward-looking statements or guidance would be detailed within the press release itself (Exhibit 99.1) and should be reviewed there for the company's future outlook.